Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2018-000545-39Phase 3Completed
Phase 3, randomised, open-label trial in actinic keratosis (AK) comparing Calcitriol pretreatment plus MAL daylight PDT with MAL daylight PDT alone (2 arms). Primary endpoint: Complete lesion response rate of actinic keratoses. Started May 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2018-000545-39.